Mohammad Azam Ansari, Takshashila Tripathi, Baskar Venkidasamy, Alan Monziani, Govindasamy Rajakumar, Mohammad N. Alomary, Sami A. Alyahya, Oriane Onimus, Naomi D’souza, Md. Abul Barkat, Ebtesam A. Al-Suhaimi, Ramkumar Samynathan & Muthu Thiruvengadam. (2023) Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers. Molecular Neurobiology.
Crossref
Dhananjay Bhatane, Sharon Rose Pamshong, Santosh Sarnaik, Prabakaran A & Amit Alexander. (2023) Potential applications of mesoporous silica nanoparticles for the treatment of neurological disorders. Journal of Drug Delivery Science and Technology 89, pages 104970.
Crossref
Lawrence J. Green, Neal D. Bhatia, Ofer Toledano, Maya Erlich, Amy Spizuoco, Benjamin C. Goodyear, Jean Philippe York & Jeannette Jakus. (2023) Silica-based microencapsulation used in topical dermatologic applications. Archives of Dermatological Research 315:10, pages 2787-2793.
Crossref
Zahra Kaboli, Mir-Jamal Hosseini, Somayeh Sadighian, Kobra Rostamizadeh, Mehrdad Hamidi & Hamidreza Kheiri Manjili. (2023) Valine conjugated polymeric nanocarriers for targeted co-delivery of rivastigmine and quercetin in rat model of Alzheimer disease. International Journal of Pharmaceutics 645, pages 123418.
Crossref
Siva Prasad Panda & Vikrant Singh. (2023) The Dysregulated MAD in Mad: A Neuro-theranostic Approach Through the Induction of Autophagic Biomarkers LC3B-II and ATG. Molecular Neurobiology 60:9, pages 5214-5236.
Crossref
Solmaz Maleki Dizaj, Seyyedeh Saba Bolouri Ebrahimi, Sadaf Jafari, Anita Basiri, Javad Yazdani, Simin Sharifi & Elaheh Dalir Abdolahinia. (2023) Co-Delivery of Cisplatin and Curcumin Using Mesoporous Silica Nanoparticles
to Improve their Anticancer Effects. Pharmaceutical Nanotechnology 11:4, pages 364-372.
Crossref
Mohammad Yousef Memar, Mina Yekani, Safar Farajnia, Farzaneh Ghadiri Moghaddam, Edris Nabizadeh, Simin Sharifi & Solmaz Maleki Dizaj. (2023) Antibacterial and biofilm-inhibitory effects of vancomycin-loaded mesoporous silica nanoparticles on methicillin-resistant staphylococcus aureus and gram-negative bacteria. Archives of Microbiology 205:4.
Crossref
Mohammad Yousef Memar, Elaheh Dalir Abdolahinia, Mina Yekani, Maryam Kouhsoltani, Simin Sharifi & Solmaz Maleki Dizaj. (2022) Preparation of rutin-loaded mesoporous silica nanoparticles and evaluation of its physicochemical, anticancer, and antibacterial properties. Molecular Biology Reports 50:1, pages 203-213.
Crossref
Simin Sharifi, Elaheh Dalir Abdolahinia, Mohammad Ali Ghavimi, Solmaz Maleki Dizaj, Michael Aschner, Luciano Saso & Haroon Khan. (2022) Effect of Curcumin-Loaded Mesoporous Silica Nanoparticles on the Head and Neck Cancer Cell Line, HN5. Current Issues in Molecular Biology 44:11, pages 5247-5259.
Crossref
Shahriar Shahi, Simin Sharifi, Rovshan Khalilov, Solmaz Maleki Dizaj & Elaheh Dalir Abdolahinia. (2022) Gelatin-hydroxyapatite Fibrous Nanocomposite for Regenerative Dentistry and bone Tissue Engineering. The Open Dentistry Journal 16:1.
Crossref
María Vallet-Regí, Ferdi Schüth, Daniel Lozano, Montserrat Colilla & Miguel Manzano. (2022) Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?. Chemical Society Reviews 51:13, pages 5365-5451.
Crossref
Georgios K. Eleftheriadis, Eleni Kontogiannidou, Christina Karavasili & Dimitrios G. Fatouros. 2022. Oral Drug Delivery for Modified Release Formulations. Oral Drug Delivery for Modified Release Formulations
161
179
.
Michael Lau, Benjamin Sealy, Valery Combes, Marco Morsch & Alfonso E. Garcia-Bennett. (2022) Enhanced Antioxidant Effects of the Anti-Inflammatory Compound Probucol When Released from Mesoporous Silica Particles. Pharmaceutics 14:3, pages 502.
Crossref
Syed Nasir Abbas Bukhari. (2022) Nanotherapeutics for Alzheimer's Disease with Preclinical Evaluation and
Clinical Trials: Challenges, Promises and Limitations. Current Drug Delivery 19:1, pages 17-31.
Crossref
Davood Gheidari & Mohammad Bayat. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
17
39
.
Pallav Namdeo, Jinu Mathew & Ashish Garg. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases
223
242
.
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tuong Kha Vo, Nguyen-Minh-An Tran, Minh Kim Nguyen, Toi Van Vo & Giau Van Vo. (2021) Nanotechnology-based drug delivery for central nervous system disorders. Biomedicine & Pharmacotherapy 143, pages 112117.
Crossref
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Thi Kim Oanh Nguyen, Tuong Kha Vo & Van Giau Vo. (2021) Advances in developing therapeutic strategies for Alzheimer's disease. Biomedicine & Pharmacotherapy 139, pages 111623.
Crossref
Sukriti Srivastava, Razi Ahmad & Sunil Kumar Khare. (2021) Alzheimer’s disease and its treatment by different approaches: A review. European Journal of Medicinal Chemistry 216, pages 113320.
Crossref
Ikram Ahmad, Hina Tabassum, Farwa Batool Shamsi, Saad Maroof Saeed, Awais Ahmad & Shahid Hussain. 2021. Nanomedicine Manufacturing and Applications. Nanomedicine Manufacturing and Applications
173
191
.
Sara Silva, António J. Almeida & Nuno Vale. (2021) Acetylcholinesterase inhibitors and nanoparticles on Alzheimer’s disease: a review. Journal of Nanoparticle Research 23:1.
Crossref
Niloufar Choubdar & Sara Avizheh. (2020) Nanotechnology Based Delivery Systems of Drugs Currently Used to Treat Alzheimer’s Disease. Nanoscience & Nanotechnology-Asia 10:3, pages 228-247.
Crossref
Anmol Dogra, R.S. Narang & Jasjeet K. Narang. (2020) Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer’s Disease. Current Pharmaceutical Design 26:19, pages 2257-2279.
Crossref
Fernanda Maria Policarpo Tonelli, Flávia Cristina Policarpo Tonelli, Danilo Roberto Carvalho Ferreira, Karine Emanuelle da Silva, Helon Guimarães Cordeiro, Amanda Tomie Ouchida & Núbia Alexandre de Melo Nunes. 2020. Intelligent Nanomaterials for Drug Delivery Applications. Intelligent Nanomaterials for Drug Delivery Applications
85
103
.
Shruti Mendiratta, Menna Hussein, Hebatallah A. Nasser & Ahmed Atef Ahmed Ali. (2019) Multidisciplinary Role of Mesoporous Silica Nanoparticles in Brain Regeneration and Cancers: From Crossing the Blood–Brain Barrier to Treatment. Particle & Particle Systems Characterization 36:9.
Crossref
Mina Najafi, Ali Morsali & Mohammad Reza Bozorgmehr. (2018) DFT study of SiO2 nanoparticles as a drug delivery system: structural and mechanistic aspects. Structural Chemistry 30:3, pages 715-726.
Crossref
Farnaz Naghavi, Ali Morsali & Mohammad Reza Bozorgmehr. (2019) Molecular mechanism study of surface functionalization of silica nanoparticle as an anticancer drug nanocarrier in aqueous solution. Journal of Molecular Liquids 282, pages 392-400.
Crossref
Paramita Basu, Rajesh Vadlapatla, Priyank Kumar & Joshua P. Gray. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
573
615
.
Alessandra Nigro, Michele Pellegrino, Marianna Greco, Alessandra Comandè, Diego Sisci, Luigi Pasqua, Antonella Leggio & Catia Morelli. (2018) Dealing with Skin and Blood-Brain Barriers: The Unconventional Challenges of Mesoporous Silica Nanoparticles. Pharmaceutics 10:4, pages 250.
Crossref
Yong-Gang Hua, Lan-Ping Han, Qian-Qian Yang, Mei-Jing Wang, En Zhang & Hong-Min Liu. (2018) A Practical and Efficient Stereoselective Synthesis of (S)-Rivastigmine and (R)-Rivastigmine. ChemistrySelect 3:5, pages 1385-1387.
Crossref
Jonas G. Croissant, Yevhen Fatieiev, Abdulaziz Almalik & Niveen M. Khashab. (2018) Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications. Advanced Healthcare Materials 7:4, pages 1700831.
Crossref